Peter Shadday becomes CEO as company is moving into a commercial-stage company, increasingly focused on U.S. market opportunitiesDr. Sabine ...

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 Priority Review granted based on positive pivotal results ...

Researchers have found in a phase 3 trials that Dupilumab significantly reduced moderate or severe COPD exacerbations ...

Despite the existence of numerous clinical practice guidelines (CPGs) for cystic fibrosis (CF), there is limited understanding of their credibility and consistency. This systematic review aims to ...

Lyn Iemma, aged 75 years at the time of writing, would not describe her life as dramatic. Born and raised in Perth, WA, Australia, this thriving but relaxed city is the place she has always called ...

Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

Linde Gas & Equipment Inc. announced today the submission of a 510(k) premarket notification application with the U.S. Food and Drug Administration (FDA) for NOXBOX® I PLUS, a nitric oxide delivery ...

Technological advancements featuring portable nebulizers and smart inhalers have improved patient adherence to treatment and ...

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

Your lungs play a vital role in keeping you healthy and energised. With rising pollution levels, changing weather patterns, ...